DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kelnor 1 / 35 (Ethynodiol Diacetate / Ethinyl Estradiol) - Summary

 

-- advertisement --

BOX WARNING

Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.

 

KELNOR 1 / 35 SUMMARY

Kelnor™ 1/35 (28 Day Regimen)
(ethynodiol diacetate and ethinyl
estradiol tablets, USP)

Kelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP): Each light yellow tablet contains 1 mg of ethynodiol diacetate and 35 mcg of ethinyl estradiol.

Kelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP) are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

KELNOR 1 / 35 NEWS HIGHLIGHTS

Media Articles Related to Kelnor 1 / 35 (Ethynodiol / Estradiol)

Blogs Comment On Election-Related Reproductive Rights Issues, World Contraception Day, HHS Rule
Source: Sexual Health / STDs News From Medical News Today [2008.09.29]

'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]

Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]

Bristol MP And Health Minister Opens City's New Sexual Health Centre, England
Source: Sexual Health / STDs News From Medical News Today [2008.10.03]

Palin Discusses Stance On Abortion Rights, EC During Interview
Source: Abortion News From Medical News Today [2008.10.02]

more>>

Published Studies Related to Kelnor 1 / 35 (Ethynodiol / Estradiol)

Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. [1979.02]

Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial. [1991.04]

Complexion changes in oral contraceptive users. Results from a phase IV multicenter trial evaluating the safety and efficacy of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms. [1991.04]

Serum and placenta levels of ethynylestradiol in presence of ethynodiol diacetate after oral administration. [1982.07]

more>>

Page last updated: 2008-10-03

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008